Martha Gomez Cuellar M.D.
About Martha Gomez Cuellar M.D.
"Medical Clinic - Integrative Medicine, Endocrinologist"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Martha Gomez Cuellar M.D.
During the past decade, Martha Gomez Cuellar M.D. conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on
average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
2013-07-10
2018-01-18
Completed
6,991
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
2013-10-01
2016-04-01
Completed
711
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections
2014-10-06
2015-08-21
Completed
908
Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
2014-11-27
2018-08-14
Completed
5,390
Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis
2015-09-01
2017-04-04
Completed
572
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Martha Gomez Cuellar M.D."
#1 collaborator was "Insulet Corporation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Martha Gomez Cuellar M.D.
According to Clinical.Site data, the most researched conditions in "Martha Gomez Cuellar M.D." are
"Type 1 Diabetes Mellitus" (2 trials), "Type 2 Diabetes" (2 trials), "Type 2 Diabetes Mellitus" (2 trials), "Diabetes" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "Martha Gomez Cuellar M.D." in a lesser frequency.
Clinical Trials Intervention Types at Martha Gomez Cuellar M.D.
Most popular intervention types in "Martha Gomez Cuellar M.D." are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Insulin Degludec" (5 trials), "Insulin Efsitora Alfa" (2 trials), "LY3209590" (2 trials), "Tirzepatide" (2 trials) and "Human regular U-500 insulin (CSII)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Martha Gomez Cuellar M.D.
The vast majority of trials in "Martha Gomez Cuellar M.D." are
8 trials for "All" genders.
Clinical Trials Status at Martha Gomez Cuellar M.D.
Currently, there are NaN active trials in "Martha Gomez Cuellar M.D.".
undefined are not yet recruiting,
undefined are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Martha Gomez Cuellar M.D.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Martha Gomez Cuellar M.D., 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".